Drug Gives Big Survival Boost Against Type of Advanced Breast Cancer

Women with HER2-positive tumors gained an average 16 more months of life with Perjeta, study finds

Source: The Doctors Lounge - Oncology - September 29, 2014 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Family Medicine, Gynecology, Nursing, Oncology, Pharmacy, News, Source Type: news